Corbus Pharmaceuticals(US:CRBP) Seeking Alpha·2025-12-11 21:42Core Viewpoint - Corbus Pharmaceuticals held an investor webinar to discuss recent results related to their single-ascending and multiple-ascending dose studies [2]. Group 1: Company Overview - Yuval Cohen, the CEO and Director of Corbus Pharmaceuticals, led the webinar and expressed gratitude for the participants' attendance [2]. - The company is focusing on forward-looking statements regarding their research and development efforts [2]. Group 2: Expert Involvement - Dr. Sarah Barenbaum, an Assistant Professor of Clinical Medicine at Weill Cornell Medical College, joined the discussion to provide insights on the data announced [3]. - Dr. Barenbaum specializes in obesity and weight-related medical complications, indicating the company's focus on relevant medical fields [3].